{"id":"W1977120772","doi":"10.1007/s10741-012-9343-x","title":"Anticoagulation in heart failure: current status and future direction","year":2012,"lang":"en","type":"review","venue":"Heart Failure Reviews","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto; University Health Network","funders":"Bayer HealthCare; Janssen Pharmaceuticals; European Society of Cardiology; National Institute for Health and Care Research","keywords":"Medicine; Rivaroxaban; Internal medicine; Cardiology; Acute coronary syndrome; Apixaban; Heart failure; Stroke (engine); Myocardial infarction; TIMI; Atrial fibrillation; Warfarin; Ejection fraction; Dabigatran; Aspirin; Coronary artery disease; Thrombolysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002420186,0.001172766,0.004615061,0.003549769,0.0003616325,0.002405149,0.001167805,0.002198585,0.004490047],"category_scores_gemma":[0.00440601,0.0005164197,0.001435774,0.005081948,0.0007306387,0.002550387,0.001082406,0.00239755,0.0008239728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001078277,"about_ca_system_score_gemma":0.00331538,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002849106,"about_ca_topic_score_gemma":0.007931107,"domain_scores_codex":[0.9991556,0.0001752598,0.0002598683,0.0001199266,0.0002365965,0.0000527159],"domain_scores_gemma":[0.9962755,0.002376115,0.0007288082,0.00003897892,0.0004500522,0.0001305366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002115466,0.00009124181,0.0007238719,0.09448977,0.0007241315,0.0001239564,0.00008973366,0.0002338469,0.0003689857,0.00136821,0.02867183,0.8729029],"study_design_scores_gemma":[0.0003831126,0.0004703288,0.007007797,0.1254299,0.007101934,0.001663334,0.0004273486,0.0004988394,0.0002836999,0.003641795,0.8529808,0.0001111676],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002699892,0.9996154,0.0000184441,0.0001684096,0.00009175802,0.000001477055,0.000005363253,0.000001668957,0.00007047621],"genre_scores_gemma":[0.0003264459,0.9991871,0.00008258034,0.0001870093,0.0001609267,0.000002765305,0.000006922422,4.06638e-7,0.0000459966],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004615061,"threshold_uncertainty_score":0.01502073,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1225119104505143,"score_gpt":0.4032108914477547,"score_spread":0.2806989809972404,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}